PD-L1/CD274 Monoklonaler Antikörper

PD-L1/CD274 Monoklonal Antikörper für FC

Wirt / Isotyp

Ratte / IgG2b, kappa

Getestete Reaktivität

Maus und mehr (1)

Anwendung

IHC, FC

Konjugation

Unkonjugiert

Publikationen(1)

CloneNo.

10F.9G2

Kat-Nr. : 65073-1-Ig

Synonyme

Cd274, PD-L1, Pdcd1lg1, Pdcd1l1, PD L1



Geprüfte Anwendungen

Erfolgreiche Detektion in FCAnti-CD3/CD28 stimulated mouse splenocytes

Empfohlene Verdünnung

AnwendungVerdünnung
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

IHCSee 1 publications below

Produktinformation

65073-1-Ig bindet in IHC, FC PD-L1/CD274 und zeigt Reaktivität mit Maus

Getestete Reaktivität Maus
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Ratte / IgG2b, kappa
Klonalität Monoklonal
Typ Antikörper
Immunogen k.A.
Vollständiger Name CD274 antigen
GenBank-ZugangsnummerBC066841
Gene symbol PD-L1
Gene ID (NCBI) 60533
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Affinitätsreinigung
Lagerungspuffer PBS with 0.09% sodium azide
LagerungsbedingungenStore at 2-8°C. Stable for one year after shipment.

Hintergrundinformationen

Programmed cell death ligand 1 (PD-L1, CD274, or B7-H1), is the first member of B7 family to be discovered. B7 family molecules are type I transmembrane proteins belonging to the immunoglobulin superfamily. In concert with their CD28 family receptors, the B7s are key regulators of the adaptive immune response. PD-L1 is suggested as a negative regulator of T and B cell, and plays important role in mediating tolerance of lymphocytes to self-antigens. It is also involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PD-1-independent manner.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
FC protocol for PD-L1/CD274 antibody 65073-1-IgDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanIHC

J Transl Med

Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer

Authors - XinJian Wang